AZP531. A peptide analog to Unacylated Ghrelin (UAG) intended to be developed as a treatment for the Prader Willi syndrome and Type 2 Diabetes. Status: preclinical-Unpartnered.
...
ASPAREC® is a PEGylated recombinant Erwinia chrysantemi-derived L-asparaginase, to be developed for the treatment of Acute Lymphoblastic Leukemia (ALL) in patients with hypersensitivity to E. coli-derived L-asparaginase. Status: Phase I, partnered (EUSA Pharma)
...
